180 Life Sciences Corp. Quarterly Operating Income (Loss) in USD from Q3 2016 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
180 Life Sciences Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2016 to Q4 2024.
  • 180 Life Sciences Corp. Operating Income (Loss) for the quarter ending December 31, 2024 was -$1.41M, a 3.17% increase year-over-year.
  • 180 Life Sciences Corp. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$6.32M, a 53.1% increase year-over-year.
  • 180 Life Sciences Corp. annual Operating Income (Loss) for 2024 was -$6.32M, a 53.1% increase from 2023.
  • 180 Life Sciences Corp. annual Operating Income (Loss) for 2023 was -$13.5M, a 24.7% increase from 2022.
  • 180 Life Sciences Corp. annual Operating Income (Loss) for 2022 was -$17.9M, a 14.4% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 -$1.41M +$46.1K +3.17% Dec 31, 2024 10-K 2025-03-31
Q3 2024 -$979K +$2.56M +72.3% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$1.85M +$1.84M +49.9% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$2.09M +$2.71M +56.4% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$1.45M +$4.19M +74.2% Dec 31, 2023 10-K 2025-03-31
Q3 2023 -$3.54M +$517K +12.7% Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$3.68M +$839K +18.6% Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$4.8M -$1.12M -30.5% Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$5.64M -$1.18M -26.4% Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$4.06M +$162K +3.85% Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$4.52M -$509K -12.7% Jun 30, 2022 10-Q 2023-08-15
Q1 2022 -$3.68M -$733K -24.9% Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$4.46M -$2.05M -84.7% Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$4.22M -$3.49M -477% Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$4.01M -$3.08M -330% Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$2.95M -$1.38M -88.2% Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$2.42M +$17.7M +88% Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$731K -$505K -224% Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$934K -$638K -215% Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$1.57M -$1.3M -491% Mar 31, 2020 10-Q 2021-07-19
Q4 2019 -$20.1M -$19.9M -11508% Dec 31, 2019 10-K 2021-07-09
Q3 2019 -$226K -$85.4K -60.9% Sep 30, 2019 10-Q/A 2021-02-05
Q2 2019 -$296K -$148K -100% Jun 30, 2019 10-Q/A 2021-02-05
Q1 2019 -$265K -$127K -92.1% Mar 31, 2019 10-Q 2020-05-22
Q4 2018 -$173K -$51.6K -42.5% Dec 31, 2018 10-K 2020-04-07
Q3 2018 -$140K +$578 +0.41% Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$148K -$97.5K -193% Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$138K -$107K -341% Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$121K -$118K Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$141K -$140K Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$50.4K Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$31.3K Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$3.11K* Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$683* Sep 30, 2016 10-Q 2017-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.